Ann: Quarterly Report and Appendix 4C, page-32

1) NUHs branding in the twitterverse is obviously not that great because you are a production stage stock with fairly low receipts in your last quarter. If it is so great perhaps your receipts should have been higher? NTI is a development stage stock so for us it is all about meeting our full study publication end point milestone and then FDA submission milestone.

2) Your comment about publications dont sell product further indicates to me that you don't understand the medical device market. Twitterverse is the last place that will help NTI obtain the authority in the autism field.

But hey, thats the difference between NTI and NUH right? NTI is in the medical device market and NUH is in the electronic consumerables market.

That is why NUH will struggle to obtain authority in the hearing aid market and also in the medical field of Auditory Processing Disorder.

NUHs attempt to indicate that it was going to lead in the APD field when all it does is amplify sound was embarrasing. It does not even resolve the underlying condition.

That is the obvious difference between NUH and NTI.